Patents by Inventor John P. Hanrahan

John P. Hanrahan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of metabolic syndrome with an sGC stimulator
    Patent number: 11389449
    Abstract: The present invention provides a method of treating a subject with metabolic syndrome by administering a stimulator of soluble guanylate cyclase (sGC) (Compound I) either alone or in combination therapy with a blood glucose lowering (antihyperglycemic or antidiabetes) medication, a blood pressure lowering (anti-hypertensive) medication, an anti-hyperlipidemic medication, or combinations thereof.
    Type: Grant
    Filed: September 14, 2018
    Date of Patent: July 19, 2022
    Assignee: Cyclerion Therapeutics, Inc.
    Inventors: John P. Hanrahan, Albert Thomas Profy, James D. Wakefield
  • TREATMENT OF METABOLIC SYNDROME WITH AN SGC STIMULATOR
    Publication number: 20200276195
    Abstract: The present invention provides a method of treating a subject with metabolic syndrome by administering a stimulator of soluble guanylate cyclase (sGC) (Compound I) either alone or in combination therapy with a blood glucose lowering (antihyperglycemic or antidiabetes) medication, a blood pressure lowering (anti-hypertensive) medication, an anti-hyperlipidemic medication, or combinations thereof.
    Type: Application
    Filed: September 14, 2018
    Publication date: September 3, 2020
    Inventors: John P. Hanrahan, Albert Thomas Profy, James D. Wakefield
  • METHODS FOR TREATING AND DIAGNOSING RESPIRATORY TRACT INFECTIONS
    Publication number: 20140336159
    Abstract: Described are methods of preventing, treating and diagnosing of a subject having a condition, such as, an inflammation or infection of the respiratory tract. Methods of treatment and prevention include administration of effective amounts of calcium salt formulations to a subject. Methods of diagnosing include the use of biomarkers and optionally the use of kits that can detect biomarkers. Further described are methods for modulating an immune response that include the modulation of Toll-like receptors.
    Type: Application
    Filed: October 5, 2012
    Publication date: November 13, 2014
    Inventors: Robert William Clarke, David L. Hava, John P. Hanrahan, Wesley Hugh Dehaan, Paulette Wright Andreotta, Stephen P. Arold, Jennifer Kenyon Saunders
  • ARFORMOTEROL AND TIOTROPIUM COMPOSITIONS AND METHODS FOR USE
    Publication number: 20140336218
    Abstract: Compositions and methods for the prevention and/or treatment of airway and/or respiratory disorders are provided. The compositions comprise arformoterol (the (R,R)-formoterol isomer) and tiotropium.
    Type: Application
    Filed: July 25, 2014
    Publication date: November 13, 2014
    Applicant: SUNOVION PHARMACEUTICALS INC.
    Inventors: Holly HUANG, Elizabeth B. GOODWIN, Kendyl M. SCHAEFER, John P. HANRAHAN, William T. ANDREWS, Paul MCGLYNN
  • ARFORMOTEROL AND TIOTROPIUM COMPOSITIONS AND METHODS FOR USE
    Publication number: 20110250242
    Abstract: Compositions and methods for the prevention and/or treatment of airway and/or respiratory disorders are provided. The compositions comprise arformoterol (the (R,R)-formoterol isomer) and tiotropium.
    Type: Application
    Filed: October 22, 2009
    Publication date: October 13, 2011
    Applicant: SUNOVION PHARMACEUTICALS INC.
    Inventors: Holly Huang, Elizabeth B. Goodwin, Kendyl M. Schaefer, John P. Hanrahan, William T. Andrews, Paul Mcglynn